196 related articles for article (PubMed ID: 37542314)
1. Three-dimensional visualization and evaluation of hilar cholangiocarcinoma resectability and proposal of a new classification.
Zhang JZ; Yang CX; Gao S; Bu JF; Li QQ; Wang HL; Yang KN; Tong SS; Qian LJ; Zhang J; Hua R; Sun YW; Yan JY; Chen W
World J Surg Oncol; 2023 Aug; 21(1):239. PubMed ID: 37542314
[TBL] [Abstract][Full Text] [Related]
2. MDCT assessment of resectability in hilar cholangiocarcinoma.
Ni Q; Wang H; Zhang Y; Qian L; Chi J; Liang X; Chen T; Wang J
Abdom Radiol (NY); 2017 Mar; 42(3):851-860. PubMed ID: 27770159
[TBL] [Abstract][Full Text] [Related]
3. Intravenous combined with intrabiliary contrast-enhanced ultrasound in the evaluation of resectability of hilar cholangiocarcinomas.
Jianxiong W; Yu W; Juyi W; Guangxia W
J Clin Ultrasound; 2022 Sep; 50(7):931-939. PubMed ID: 35808898
[TBL] [Abstract][Full Text] [Related]
4. Surgical resection for hilar cholangiocarcinoma: experience improves resectability.
Cannon RM; Brock G; Buell JF
HPB (Oxford); 2012 Feb; 14(2):142-9. PubMed ID: 22221577
[TBL] [Abstract][Full Text] [Related]
5. Individualized preoperative planning using three-dimensional modeling for Bismuth and Corlette type III hilar cholangiocarcinoma.
Zeng N; Tao H; Fang C; Fan Y; Xiang N; Yang J; Zhu W; Liu J; Guan T; Fang C; Xiang F
World J Surg Oncol; 2016 Feb; 14(1):44. PubMed ID: 26911245
[TBL] [Abstract][Full Text] [Related]
6. How to Determine Unresectability in Hilar Cholangiocarcinoma.
Pratt CG; Whitrock JN; Shah SA; Fong ZV
Surg Clin North Am; 2024 Feb; 104(1):197-214. PubMed ID: 37953036
[TBL] [Abstract][Full Text] [Related]
7. Role of a pre-operative radiological scoring system in determining resectability for potentially resectable hilar cholangiocarcinoma.
Bird N; McKenna A; Dunne D; Francis B; Fenwick S; Poston G; Jones R; Malik H
Eur J Surg Oncol; 2019 Feb; 45(2):192-197. PubMed ID: 30297275
[TBL] [Abstract][Full Text] [Related]
8. Predictive model for the intraoperative unresectability of hilar cholangiocarcinoma: Reducing futile surgical exploration.
Song J; Lei X; Lin H; Dai H; Liu X; Jiang Y; Hu F; Li Y; Fan H; Zhang L; Chen Z; Zhang C
PLoS One; 2022; 17(4):e0258522. PubMed ID: 35417458
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and Prognostic Role of 18-FDG PET/CT in the Management of Resectable Biliary Tract Cancer.
Ma KW; Cheung TT; She WH; Chok KSH; Chan ACY; Dai WC; Chiu WH; Lo CM
World J Surg; 2018 Mar; 42(3):823-834. PubMed ID: 28905105
[TBL] [Abstract][Full Text] [Related]
10. The Blumgart preoperative staging system for hilar cholangiocarcinoma: analysis of resectability and outcomes in 380 patients.
Matsuo K; Rocha FG; Ito K; D'Angelica MI; Allen PJ; Fong Y; Dematteo RP; Gonen M; Endo I; Jarnagin WR
J Am Coll Surg; 2012 Sep; 215(3):343-55. PubMed ID: 22749003
[TBL] [Abstract][Full Text] [Related]
11. Should more aggressive surgical resection be considered in the treatment for Bismuth types I and II hilar cholangiocarcinoma? A meta-analysis.
Hu YF; Hu HJ; Lv TR; He ZQ; Dai YS; Li FY
Asian J Surg; 2023 Oct; 46(10):4115-4123. PubMed ID: 36586821
[TBL] [Abstract][Full Text] [Related]
12. The Impact of Intraoperative Re-Resection of a Positive Bile Duct Margin on Clinical Outcomes for Hilar Cholangiocarcinoma.
Zhang XF; Squires MH; Bagante F; Ethun CG; Salem A; Weber SM; Tran T; Poultsides G; Son AY; Hatzaras I; Jin L; Fields RC; Weiss M; Scoggins C; Martin RCG; Isom CA; Idrees K; Mogal HD; Shen P; Maithel SK; Schmidt CR; Pawlik TM
Ann Surg Oncol; 2018 May; 25(5):1140-1149. PubMed ID: 29470820
[TBL] [Abstract][Full Text] [Related]
13. Evolution of surgery for Klatskin tumor demonstrates improved outcome: a single center analysis.
Yan Y; Lu N; Tian W; Liu T
Tumori; 2014; 100(6):e250-6. PubMed ID: 25688507
[TBL] [Abstract][Full Text] [Related]
14. Hilar cholangiocarcinoma: the Memorial Sloan-Kettering Cancer Center experience.
Rocha FG; Matsuo K; Blumgart LH; Jarnagin WR
J Hepatobiliary Pancreat Sci; 2010 Jul; 17(4):490-6. PubMed ID: 19806295
[TBL] [Abstract][Full Text] [Related]
15. Assessment of clinical outcomes of advanced hilar cholangiocarcinoma.
Chen KJ; Yang FC; Qin YS; Jin J; Zheng SS
Hepatobiliary Pancreat Dis Int; 2018 Apr; 17(2):155-162. PubMed ID: 29636302
[TBL] [Abstract][Full Text] [Related]
16. Lymphocyte to Monocyte Ratio Predicts Resectability and Early Recurrence of Bismuth-Corlette Type IV Hilar Cholangiocarcinoma.
Peng D; Lu J; Hu H; Li B; Ye X; Cheng N
J Gastrointest Surg; 2020 Feb; 24(2):330-340. PubMed ID: 30671792
[TBL] [Abstract][Full Text] [Related]
17. The value of total caudate lobe resection for hilar cholangiocarcinoma: a systematic review.
Wang D; Xiong F; Wu G; Wang Q; Chen J; Liu W; Wang B; Chen Y
Int J Surg; 2024 Jan; 110(1):385-394. PubMed ID: 37738006
[TBL] [Abstract][Full Text] [Related]
18. Imaging modality of three-dimensional CT in caudate cholangioma: assessment for resectability.
Yamazaki S; Takayama T; Watanabe Y; Oikawa T; Hayashi Y; Kochi M; Moriguchi M; Higaki T; Inoue K
Hepatogastroenterology; 2007 Mar; 54(74):397-9. PubMed ID: 17523283
[TBL] [Abstract][Full Text] [Related]
19. High-resolution computed tomography accurately predicts resectability in hilar cholangiocarcinoma.
Aloia TA; Charnsangavej C; Faria S; Ribero D; Abdalla EK; Vauthey JN; Curley SA
Am J Surg; 2007 Jun; 193(6):702-6. PubMed ID: 17512280
[TBL] [Abstract][Full Text] [Related]
20. Preoperative biliary drainage in patients with hilar cholangiocarcinoma undergoing major hepatectomy.
Xiong JJ; Nunes QM; Huang W; Pathak S; Wei AL; Tan CL; Liu XB
World J Gastroenterol; 2013 Dec; 19(46):8731-9. PubMed ID: 24379593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
